Skip to main content Accessibility help
  • Print publication year: 2011
  • Online publication date: April 2011

Chapter 61 - Induction of anesthesia

Related content

Powered by UNSILO


1. Lundy JS. Intravenous anesthesia: preliminary report of the use of two new thiobarbiturates. Proc Staff Meet Mayo Clin 1935; 10: 536–43.
2. Price HL. General anesthetics, cont.: Intravenous anesthetics. In: Goodman LS, Gilman A, Gilman AG, Koelle GB, eds., The Pharmacological Basis of Therapeutics, 5th edn. New York, NY: MacMillan, 1975: 97–101.
3. Payne JP. Awareness and its medicolegal implications. Br J Anaesth 1994; 73: 38–45.
4. Bennetts FE. Thiopentone anaesthesia at Pearl Harbor. Br J Anaesth 1995; 75: 366–8.
5. Kidd AG, Restall J. Thiopentone anaesthesia at Pearl Harbor. Br J Anaesth 1995; 75: 823.
6. Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM. Etomidate, R-(+)-ethyl-1-(-methyl-benzyl)imidazole-5-carboxylate (R 16659), a potent, short-acting and relatively atoxic intravenous hypnotic agent in rats. Arzneimittelforschung 1971; 21: 1234–43.
7. Stanley TH, Egan TD, Van Aken H. A tribute to Dr. Paul A. J. Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology. Anesth Analg 2008; 106: 451–62.
8. Nathan N, Odin I. Induction of anaesthesia: a guide to drug choice. Drugs 2007; 67: 701–23.
9. Struys MM, Coppens MJ, De Neve N, et al. Influence of administration rate on propofol plasma-effect site equilibration. Anesthesiology 2007; 107: 386–96.
10. Henthorn TK, Krejcie TC, Avram MJ. Early drug distribution: a generally neglected aspect of pharmacokinetics of particular relevance to intravenously administered anesthetic agents. Clin Pharmacol Ther 2008; 84: 18–22.
11. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74: 53–63.
12. Groenendaal D, Freijer J, Rosier A, et al. Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics. Eur J Pharm Sci 2008; 34: 149–63.
13. Lotsch J, Skarke C, Schmidt H, Grosch S, Geisslinger G. The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers. Anesthesiology 2001; 95: 1329–38.
14. Berthoud MC, McLaughlan GA, Broome IJ, et al. Comparison of infusion rates of three i.v. anaesthetic agents for induction in elderly patients. Br J Anaesth 1993; 70: 423–7.
15. Peacock JE, Spiers SP, McLauchlan GA, et al. Infusion of propofol to identify smallest effective doses for induction of anaesthesia in young and elderly patients. Br J Anaesth 1992; 69: 363–7.
16. Stokes DN, Hutton P. Rate-dependent induction phenomena with propofol: implications for the relative potency of intravenous anesthetics. Anesth Analg 1991; 72: 578–83.
17. Rolly G, Versichelen L, Huyghe L, Mungroop H. Effect of speed of injection on induction of anaesthesia using propofol. Br J Anaesth 1985; 57: 743–6.
18. Schmartz D, Ferring M, Ducart A, Barvais L. Haemodynamics during remifentanil induction by high plasma or effect-site target controlled infusion. Acta Anaesthesiol Belg 2007; 58: 15–18.
19. Doufas AG, Bakhshandeh M, Bjorksten AR, Shafer SL, Sessler DI. Induction speed is not a determinant of propofol pharmacodynamics. Anesthesiology 2004; 101: 1112–21.
20. Wong KC. Narcotics are not expected to produce unconsciousness and amnesia. Anesth Analg 1983; 62: 625–6.
21. McDonnell TE, Bartkowski RR, Williams JJ. ED50 of alfentanil for induction of anesthesia in unpremedicated young adults. Anesthesiology 1984; 60: 136–40.
22. Vinik HR, Bradley EL, Kissin I. Midazolam-alfentanil synergism for anesthetic induction in patients. Anesth Analg 1989; 69: 213–17.
23. Jhaveri R, Joshi P, Batenhorst R, Baughman V, Glass PS. Dose comparison of remifentanil and alfentanil for loss of consciousness. Anesthesiology 1997; 87: 253–9.
24. Bowdle TA, Ward RJ. Induction of anesthesia with small doses of sufentanil or fentanyl: dose versus EEG response, speed of onset and thiopental requirement. Anesthesiology 1989; 70: 26–30.
25. Baum VC, Yemen TA, Baum LD. Immediate 8% sevoflurane induction in children: a comparison with incremental sevoflurane and incremental halothane. Anesth Analg 1997; 85: 313–16.
26. Hall JE, Stewart JI, Harmer M. Single-breath inhalation induction of sevoflurane anaesthesia with and without nitrous oxide: a feasibility study in adults and comparison with an intravenous bolus of propofol. Anaesthesia 1997; 52: 410–15.
27. Lejus C, Bazin V, Fernandez M, et al. Inhalation induction using sevoflurane in children: the single-breath vital capacity technique compared to the tidal volume technique. Anaesthesia 2006; 61: 535–40.
28. Philip BK, Lombard LL, Roaf ER, et al. Comparison of vital capacity induction with sevoflurane to intravenous induction with propofol for adult ambulatory anesthesia. Anesth Analg 1999; 89: 623–7.
29. Thwaites A, Edmends S, Smith I. Inhalation induction with sevoflurane: a double-blind comparison with propofol. Br J Anaesth 1997; 78: 356–61.
30. Joo HS, Perks WJ. Sevoflurane versus propofol for anesthetic induction: a meta-analysis. Anesth Analg 2000; 91: 213–19.
31. Cros AM, Lopez C, Kandel T, Sztark F. Determination of sevoflurane alveolar concentration for tracheal intubation with remifentanil, and no muscle relaxant. Anaesthesia 2000; 55: 965–9.
32. Wax PM, Becker CE, Curry SC. Unexpected “gas” casualties in Moscow: a medical toxicology perspective. Ann Emerg Med 2003; 41: 700–5.
33. Stanley T. Human immobilization: is the experience in Moscow just the beginning? Eur J Anaesthesiol 2003; 20: 427–8.
34. Baillard C, Adnet F, Borron SW, et al. Tracheal intubation in routine practice with and without muscular relaxation: an observational study. Eur J Anaesthesiol 2005; 22: 672–7.
35. Erhan E, Ugur G, Gunusen I, Alper I, Ozyar B. Propofol – not thiopental or etomidate – with remifentanil provides adequate intubating conditions in the absence of neuromuscular blockade. Can J Anaesth 2003; 50: 108–15.
36. Taha S, Siddik-Sayyid S, Alameddine M, et al. Propofol is superior to thiopental for intubation without muscle relaxants. Can J Anaesth 2005; 52: 249–53.
37. Hendrickx JF, Eger EI, Sonner JM, Shafer SL. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth Analg 2008; 107: 494–506.
38. Vinik HR, Bradley EL, Kissin I. Midazolam–alfentanil synergism for anesthetic induction in patients. Anesth Analg 1989; 69: 213–17.
39. Mertens MJ, Olofsen E, Engbers FH, et al. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology 2003; 99: 347–59.
40. Johnson KB, Syroid ND, Gupta DK, et al. An evaluation of remifentanil propofol response surfaces for loss of responsiveness, loss of response to surrogates of painful stimuli and laryngoscopy in patients undergoing elective surgery. Anesth Analg 2008; 106: 471–9.
41. Vuyk J, Lim T, Engbers FH, et al. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. Anesthesiology 1995; 83: 8–22.
42. Kissin I, Brown PT, Bradley EL. Morphine and fentanyl anesthetic interactions with etomidate. Anesthesiology 1987; 67: A383.
43. Tverskoy M, Fleyshman G, Bradley EL, Kissin I. Midazolam-thiopental anesthetic interaction in patients. Anesth Analg 1988; 67: 342–5.
44. Short TG, Plummer JL, Chui PT. Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. Br J Anaesth 1992; 69: 162–7.
45. Vinik HR, Bradley EL, Kissin I. Triple anesthetic combination: propofol–midazolam–alfentanil. Anesth Analg 1994; 78: 354–8.
46. Roytblat L, Katz J, Rozentsveig V, et al. Anaesthetic interaction between thiopentone and ketamine. Eur J Anaesthesiol 1992; 9: 307–12.
47. Hong W, Short TG, Hui TW. Hypnotic and anesthetic interactions between ketamine and midazolam in female patients. Anesthesiology 1993; 79: 1227–32.
48. Vinik HR, Bradley EL, Kissin I. Isobolographic analysis of propofol–thiopental hypnotic interaction in surgical patients. Anesth Analg 1999; 88: 667–70.
49. Sztark F, Chopin F, Bonnet A, Cros AM. Concentration of remifentanil needed for tracheal intubation with sevoflurane at 1 MAC in adult patients. Eur J Anaesthesiol 2005; 22: 919–24.
50. Katoh T, Nakajima Y, Moriwaki G, et al. Sevoflurane requirements for tracheal intubation with and without fentanyl. Br J Anaesth 1999; 82: 561–5.
51. Sivalingam P, Kandasamy R, Dhakshinamoorthi P, Madhavan G. Tracheal intubation without muscle relaxant: a technique using sevoflurane vital capacity induction and alfentanil. Anaesth Intensive Care 2001; 29: 383–7.
52. Tomicheck RC, Rosow CE, Philbin DM, et al. Diazepam–fentanyl interaction: hemodynamic and hormonal effects in coronary artery surgery. Anesth Analg 1983; 62: 881–4.
53. Billard V, Moulla F, Bourgain JL, Megnigbeto A, Stanski DR. Hemodynamic response to induction and intubation. Propofol/fentanyl interaction. Anesthesiology 1994; 81: 1384–93.
54. Bailey PL, Pace NL, Ashburn MA, et al. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990; 73: 826–30.
55. Graf BM, Vicenzi MN, Martin E, Bosnjak ZJ, Stowe DF. Ketamine has stereospecific effects in the isolated perfused guinea pig heart. Anesthesiology 1995; 82: 1426–37; discussion 25A.
56. Weiskopf RB, Bogetz MS, Roizen MF, Reid IA. Cardiovascular and metabolic sequelae of inducing anesthesia with ketamine or thiopental in hypovolemic swine. Anesthesiology 1984; 60: 214–19.
57. Gelissen HP, Epema AH, Henning RH, et al. Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology 1996; 84: 397–403.
58. Vanlersberghe C, Camu F. Etomidate and other non-barbiturates. Handb Exp Pharmacol 2008; 182: 267–82.
59. Ebert TJ. Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans. Anesthesiology 2005; 103: 20–4.
60. Flacke JW, Davis LJ, Flacke WE, Bloor BC, Van Etten AP. Effects of fentanyl and diazepam in dogs deprived of autonomic tone. Anesth Analg 1985; 64: 1053–9.
61. Flacke JW, Flacke WE, Bloor BC, Olewine S. Effects of fentanyl, naloxone, and clonidine on hemodynamics and plasma catecholamine levels in dogs. Anesth Analg 1983; 62: 305–13.
62. Cardinal V, Martin R, Tetrault JP, et al. [Severe bradycardia and asystole with low dose sufentanil during induction with sevoflurane: a report of three cases]. Can J Anaesth 2004; 51: 806–9.
63. Egan TD, Brock-Utne JG. Asystole after anesthesia induction with a fentanyl, propofol, and succinylcholine sequence. Anesth Analg 1991; 73: 818–20.
64. Starr NJ, Sethna DH, Estafanous FG. Bradycardia and asystole following the rapid administration of sufentanil with vecuronium. Anesthesiology 1986; 64: 521–3.
65. O'Connor JP, Ramsay JG, Wynands JE, et al. The incidence of myocardial ischemia during anesthesia for coronary artery bypass surgery in patients receiving pancuronium or vecuronium. Anesthesiology 1989; 70: 230–6.
66. Gravlee GP, Ramsey FM, Roy RC, et al. Rapid administration of a narcotic and neuromuscular blocker: a hemodynamic comparison of fentanyl, sufentanil, pancuronium, and vecuronium. Anesth Analg 1988; 67: 39–47.
67. Thomson IR, Putnins CL. Adverse effects of pancuronium during high-dose fentanyl anesthesia for coronary artery bypass grafting. Anesthesiology 1985; 62: 708–13.
68. Podolakin W, Wells DG. Precipitous bradycardia induced by laryngoscopy in cardiac surgical patients. Can J Anaesth 1987; 34: 618–21.
69. Mizuno J, Mizuno S, Ono N, et al. [Sinus arrest during laryngoscopy for induction of general anesthesia with intravenous fentanyl and propofol]. Masui 2005; 54: 1030–3.
70. Macario A, Weinger M, Truong P, Lee M. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg 1999; 88: 1085–91.
71. Akeson J. Pain on injection of propofol – why bother? Acta Anaesthesiol Scand 2008; 52: 591–3.
72. Lee P, Russell WJ. Preventing pain on injection of propofol: a comparison between lignocaine pre-treatment and lignocaine added to propofol. Anaesth Intensive Care 2004; 32: 482–4.
73. Thorn-Alquist AM. Parenteral use of diazepam in an emulsion formulation. A clinical study. Acta Anaesthesiol Scand 1977; 21: 400–4.
74. Schou Olesen A, Huttel MS. Local reactions to i.v. diazepam in three different formulations. Br J Anaesth 1980; 52: 609–11.
75. Andersin R. Solubility and acid-base behaviour of midazolam in media of different pH, studied by ultraviolet spectrophotometry with multicomponent software. J Pharm Biomed Anal 1991; 9: 451–5.
76. Gerecke M. Chemical structure and properties of midazolam compared with other benzodiazepines. Br J Clin Pharmacol 1983; 16: 11S–16S.
77. Gibiansky E, Struys MM, Gibiansky L, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics. Anesthesiology 2005; 103: 718–29.
78. Struys MM, Vanluchene AL, Gibiansky E, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety. Anesthesiology 2005; 103: 730–43.
79. Gan TJ. Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation. Clin Pharmacokinet 2006; 45: 855–69.
80. Shah A, Mistry B, Gibiansky E, Gibiansky L. Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation. Anesthesiology 2008; 109: 937.
81. Reddy RV, Moorthy SS, Dierdorf SF, Deitch RD, Link L. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg 1993; 77: 1008–11.
82. Smith NT, Benthuysen JL, Bickford RG, et al. Seizures during opioid anesthetic induction: are they opioid-induced rigidity? Anesthesiology 1989; 71: 852–62.
83. Armstrong PJ, Bersten A. Normeperidine toxicity. Anesth Analg 1986; 65: 536–8.
84. Bowdle TA. Myoclonus following sufentanil without EEG seizure activity. Anesthesiology 1987; 67: 593–5.
85. Tempelhoff R, Modica PA, Bernardo KL, Edwards I. Fentanyl-induced electrocorticographic seizures in patients with complex partial epilepsy. J Neurosurg 1992; 77: 201–8.
86. Cascino GD, So EL, Sharbrough FW, et al. Alfentanil-induced epileptiform activity in patients with partial epilepsy. J Clin Neurophysiol 1993; 10: 520–5.
87. Wass CT, Grady RE, Fessler AJ, et al. The effects of remifentanil on epileptiform discharges during intraoperative electrocorticography in patients undergoing epilepsy surgery. Epilepsia 2001; 42: 1340–4.
88. Streisand JB, Bailey PL, LeMaire L, et al. Fentanyl-induced rigidity and unconsciousness in human volunteers. Incidence, duration, and plasma concentrations. Anesthesiology 1993; 78: 629–34.
89. Grell FL, Koons RA, Denson JS. Fentanyl in anesthesia: a report of 500 cases. Anesth Analg 1970; 49: 523–32.
90. Waller JL, Hug CC, Nagle DM, Craver JM. Hemodynamic changes during fentanyl–oxygen anesthesia for aortocoronary bypass operation. Anesthesiology 1981; 55: 212–17.
91. Benthuysen JL, Smith NT, Sanford TJ, Head N, Dec-Silver H. Physiology of alfentanil-induced rigidity. Anesthesiology 1986; 64: 440–6.
92. Weinger MB, Smith NT, Blasco TA, Koob GF. Brain sites mediating opiate-induced muscle rigidity in the rat: methylnaloxonium mapping study. Brain Res 1991; 544: 181–90.
93. Bailey PL, Wilbrink J, Zwanikken P, Pace NL, Stanley TH. Anesthetic induction with fentanyl. Anesth Analg 1985; 64: 48–53.
94. Blasco TA, Smith NT, Sanford TJ, et al. A clinical study of the effects of various pretreatment agents on alfentanil-induced rigidity: EMG data Anesthesiology 1985; 63: A380.
95. Weinger MB, Segal IS, Maze M. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat. Anesthesiology 1989; 71: 242–9.
96. Weinger MG, Cline EJ, Smith NT, Koob GF. Ketanserin pretreatment reverses alfentanil-induced muscle rigidity. Anesthesiology 1987; 67: 348–54.
97. Vacanti CA, Silbert BS, Vacanti FX. The effects of thiopental sodium on fentanyl-induced muscle rigidity in a human model. J Clin Anesth 1991; 3: 395–8.
98. Bowdle TA, Radant AD, Cowley DS, et al. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 1998; 88: 82–8.
99. Johnson KB, Egan TD, Kern SE, et al. The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 2003; 99: 409–20.
100. Johnson KB, Egan TD, Layman J, et al. The influence of hemorrhagic shock on etomidate: a pharmacokinetic and pharmacodynamic analysis. Anesth Analg 2003; 96: 1360–8.
101. Egan TD, Kuramkote S, Gong G, et al. Fentanyl pharmacokinetics in hemorrhagic shock: a porcine model. Anesthesiology 1999; 91: 156–66.
102. Johnson KB, Kern SE, Hamber EA, et al. Influence of hemorrhagic shock on remifentanil: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 2001; 94: 322–32.
103. Johnson KB, Egan TD, Kern SE, et al. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 2004; 101: 647–59.
104. Takizawa E, Takizawa D, Hiraoka H, Saito S, Goto F. Disposition and pharmacodynamics of propofol during isovolaemic haemorrhage followed by crystalloid resuscitation in humans. Br J Clin Pharmacol 2006; 61: 256–61.
105. Neilipovitz DT, Crosby ET. No evidence for decreased incidence of aspiration after rapid sequence induction. Can J Anaesth 2007; 54: 748–64.
106. Weiss M, Gerber AC. Rapid sequence induction in children: it's not a matter of time! Paediatr Anaesth 2008; 18: 97–9.
107. Smith KJ, Ladak S, Choi PT, Dobranowski J. The cricoid cartilage and the esophagus are not aligned in close to half of adult patients. Can J Anaesth 2002; 49: 503–7.
108. Garrard A, Campbell AE, Turley A, Hall JE. The effect of mechanically-induced cricoid force on lower oesophageal sphincter pressure in anaesthetised patients. Anaesthesia 2004; 59: 435–9.
109. Ellis DY, Harris T, Zideman D. Cricoid pressure in emergency department rapid sequence tracheal intubations: a risk-benefit analysis. Ann Emerg Med 2007; 50: 653–65.
110. Butler J, Sen A. Best evidence topic report. Cricoid pressure in emergency rapid sequence induction. Emerg Med J 2005; 22: 815–16.
111. Engelhardt T, Webster NR. Pulmonary aspiration of gastric contents in anaesthesia. Br J Anaesth 1999; 83: 453–60.
112. Perry JJ, Lee JS, Sillberg VA, Wells GA. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev 2008; 2: CD002788.
113. Ledowski T, Wulf H. The influence of fentanyl vs. s-ketamine on intubating conditions during induction of anaesthesia with etomidate and rocuronium. Eur J Anaesthesiol 2001; 18: 519–23.
114. Chidiac EJ, Raiskin AO. Succinylcholine and the open eye. Ophthalmol Clin North Am 2006; 19: 279–85.
115. Vinik HR. Intravenous Drug Interactions. In: White PF, ed., Textbook of Intravenous Anesthesia. Baltimore, MD: Williams and Wilkins, 1997: 447–58.
116. Brown RH, Wagner EM. Mechanisms of bronchoprotection by anesthetic induction agents: propofol versus ketamine. Anesthesiology 1999; 90: 822–8.
117. Ouedraogo N, Roux E, Forestier F, et al. Effects of intravenous anesthetics on normal and passively sensitized human isolated airway smooth muscle. Anesthesiology 1998; 88: 317–26.
118. Eames WO, Rooke GA, Wu RS, Bishop MJ. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology 1996; 84: 1307–11.
119. Burburan SM, Xisto DG, Rocco PR. Anaesthetic management in asthma. Minerva Anestesiol 2007; 73: 357–65.
120. Goff MJ, Arain SR, Ficke DJ, Uhrich TD, Ebert TJ. Absence of bronchodilation during desflurane anesthesia: a comparison to sevoflurane and thiopental. Anesthesiology 2000; 93: 404–8.
121. Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987; 66: 723–30.
122. Bowdle TA, Even A, Shen DD, Swardstrom M. Methadone for the induction of anesthesia: plasma histamine concentration, arterial blood pressure, and heart rate. Anesth Analg 2004; 98: 1692–7.
123. Kim ES, Bishop MJ. Endotracheal intubation, but not laryngeal mask airway insertion, produces reversible bronchoconstriction. Anesthesiology 1999; 90: 391–4.
124. Longnecker DE. Stress free: to be or not to be? Anesthesiology 1984; 61: 643–4.
125. Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 1999; 54: 861–7.
126. Sacchetti A. Etomidate: not worth the risk in septic patients. Ann Emerg Med 2008; 52: 14–16.
127. Hildreth AN, Mejia VA, Maxwell RA, et al. Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. J Trauma 2008; 65: 573–9.
128. Mohammad Z, Afessa B, Finkielman JD. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care 2006; 10: R105.
129. den Brinker M, Joosten KF, Liem O, et al. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005; 90: 5110–17.
130. Cotton BA, Guillamondegui OD, Fleming SB, et al. Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients. Arch Surg 2008; 143: 62–7.
131. Schenarts CL, March JA. Corticosteroids for patients with septic shock. JAMA 2003; 289: 41; author reply 43–4.
132. Walls RM, Murphy MF. Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock. Ann Emerg Med 2008; 52: 13–14.
133. Igaz P, Tombol Z, Szabo PM, Liko I, Racz K. Steroid biosynthesis inhibitors in the therapy of hypercortisolism: theory and practice. Curr Med Chem 2008; 15: 2734–47.
134. Zolle IM, Berger ML, Hammerschmidt F, et al. New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure–activity relationship of potent etomidate analogues. J Med Chem 2008; 51: 2244–53.
135. Brimacombe JR. Placement Phase. In: Laryngeal Mask Anesthesia: Principles and Practice, 2nd edn., Philadelphia, PA: Saunders, 2005: 191–240.
136. Russell D, Wilkes MP, Hunter SC, et al. Manual compared with target-controlled infusion of propofol. Br J Anaesth 1995; 75: 562–6.
137. Mackie AM, Watson CB. Anaesthesia and mediastinal masses: a case report and review of the literature. Anaesthesia 1984; 39: 899–903.
138. Slinger P, Karsli C. Management of the patient with a large anterior mediastinal mass: recurring myths. Curr Opin Anaesthesiol 2007; 20: 1–3.
139. Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg 2005; 101: 524–34.
140. Sehdev RS, Symmons DA, Kindl K. Ketamine for rapid sequence induction in patients with head injury in the emergency department. Emerg Med Australas 2006; 18: 37–44.
141. Milde LN, Milde JH, Gallagher WJ. Effects of sufentanil on cerebral circulation and metabolism in dogs. Anesth Analg 1990; 70: 138–46.
142. Sperry RJ, Bailey PL, Reichman MV, et al. Fentanyl and sufentanil increase intracranial pressure in head trauma patients. Anesthesiology 1992; 77: 416–20.
143. Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Safety 1998; 19: 173–89.
144. Artru AA. Effects of fentanyl, sufentanil, and alfentanil on epileptiform EEG activity, cerebral blood flow, and intracranial pressure. In: Hines R, Bowdle TA. , eds., Anesthesiology Clinics of North America Annual of Anesthetic Pharmacology. Philadelphia, PA: WB Saunders, 1997: 117–54.
145. Fodale V, Schifilliti D, Pratico C, Santamaria LB. Remifentanil and the brain. Acta Anaesthesiol Scand 2008; 52: 319–26.
146. Coates D. “Diprifusor” for general and day-case surgery. Anaesthesia 1998; 53: 46–8.
147. Engbers F. Practical use of “Diprifusor” systems. Anaesthesia 1998; 53: 28–34.
148. Glen JB. The development of “Diprifusor”: a TCI system for propofol. Anaesthesia 1998; 53: 13–21.
149. Gray JM, Kenny GN. Development of the technology for “Diprifusor” TCI systems. Anaesthesia 1998; 53: 22–7.
150. Huggins NJ. “Diprifusor” for neurosurgical procedures. Anaesthesia 1998; 53: 53–5.
151. Milne SE, Kenny GN. Future applications for TCI systems. Anaesthesia 1998; 53 : 56–60.
152. Richards AL, Orton JK, Gregory MJ. Influence of ventilatory mode on target concentrations required for anaesthesia using a “Diprifusor” TCI system. Anaesthesia 1998; 53: 77–81.
153. Russell D. Intravenous anaesthesia: manual infusion schemes versus TCI systems. Anaesthesia 1998; 53: 42–5.
154. Servin FS. TCI compared with manually controlled infusion of propofol: a multicentre study. Anaesthesia 1998; 53: 82–6.
155. Servin FS, Marchand-Maillet F, Desmonts JM. Influence of analgesic supplementation on the target propofol concentrations for anaesthesia with “Diprifusor” TCI. Anaesthesia 1998; 53: 72–6.
156. Struys M, Versichelen L, Rolly G. Influence of pre-anaesthetic medication on target propofol concentration using a “Diprifusor” TCI system during ambulatory surgery. Anaesthesia 1998; 53: 68–71.
157. Sutcliffe NP, Hyde R, Martay K. Use of “Diprifusor” in anaesthesia for ophthalmic surgery. Anaesthesia 1998; 53: 49–52.
158. Swinhoe CF, Peacock JE, Glen JB, Reilly CS. Evaluation of the predictive performance of a “Diprifusor” TCI system. Anaesthesia 1998; 53: 61–7.
159. Leslie K, Clavisi O, Hargrove J. Target-controlled infusion versus manually-controlled infusion of propofol for general anaesthesia or sedation in adults. Cochrane Database Syst Rev 2008; (3): CD006059.
160. Jack ES, Shaw M, Harten JM, Anderson K, Kinsella J. Cardiovascular changes after achieving constant effect site concentration of propofol. Anaesthesia 2008; 63: 116–20.
161. Manberg PJ, Vozella CM, Kelley SD. Regulatory challenges facing closed-loop anesthetic drug infusion devices. Clin Pharmacol Ther 2008; 84: 166–9.
162. Bazaral MG, Ciarkowski A. Food and drug administration regulations and computer-controlled infusion pumps. Int Anesthesiol Clin 1995; 33: 45–63.
163. Hogue CW, Bowdle TA, O'Leary C, et al. A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg 1996; 83: 279–85.